Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
14 rezultatima
Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
A total of 304 patients with a clinical diagnosis of palmar-type tinea pedis or manus and a positive mycologic examination were recruited into this double-blind, randomized, multicenter, phase III study. Patients were randomized to receive either oral itraconazole 200 mg twice daily (in the morning
Itraconazole oral solution for the treatment of tinea capitis.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Twenty-seven children (12 boys, 15 girls, age range 3-11 years, weight range 10-40 kg) were treated with itraconazole oral solution 10 mg/mL given as pulse therapy for tinea capitis. The dosage regimen was 3 mg/kg per day given once daily in a fasting state with each pulse lasting 1 week. The first
Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Tinea capitis is a relatively common fungal infection of childhood. Griseofulvin has been the mainstay of management. However, newer oral antifungal agents are being used more frequently. A multicenter, prospective, randomized, single-blinded, non-industry-sponsored study was conducted in centers in
Treatment of dermatophytoses and pityriasis versicolor with itraconazole.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Thirty patients (18 males and 12 females) with dermatophytoses were treated with itraconazole. Twenty-eight patients received 100 mg per day for 14 days, and two patients, one with tinea pedis and one with tinea manuum, were treated for 28 days. Thirty patients (11 males and 19 females) with
Itraconazole in the treatment of tinea capitis in children. Case reports with long-term follow-up evaluation. Review of the literature.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Although griseofulvin is considered the standard treatment of tinea capitis in children, alternatives are being investigated. Our purpose was to determine the efficacy of itraconazole for kerion and noninflammatory tinea capitis. An open label study was performed on five patients. It was planned to
Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Toenail tinea is a very recalcitrant dermatosis. Griseofulvin at > or = 500 mg/day is the current medication of choice, but it is minimally successful. In a controlled open trial ultramicrosize griseofulvin (UMSG) at doses of 660 and 990 mg/day was compared with itraconazole at 100 mg/day in 109
Itraconazole in the treatment of tinea corporis and tinea cruris.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Forty-five patients with tinea corporis or tinea cruris were treated with oral itraconazole 100 mg daily for 15 days. At the end of the 15-day treatment, 80% of the patients were healed or had markedly improved. At the first follow-up visit, 2 weeks after stopping therapy, 80% of patients were
Griseofulvin in the mass treatment of tinea capitis.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The prevalence of ringworm of the scalp in many countries, and the fact that many of the current measures to control it are inconvenient for mass use, lend particular interest to the account given in this paper of mass treatment of tinea capitis in an Arab village in Israel. A total of 446 cases
Treatment of dermatomycoses with ketoconazole.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Forty patients (22 males and 18 nonpregnant females) with tegumentary mycoses were treated with ketoconazole (R41,400). The group included 39 patients with dermatophytoses and one with tinea versicolor. Ketoconazole was administered in one dose per day taken with water 2 hr before or after breakfast
Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Trichotillomania (TTM) is defined by the Diagnostics and Statistic Manual of Mental Disorders, 4th edition (DMS-IV) as hair loss from a patient`s repetitive self-pulling of hair. The disorder is included under anxiety disorders because it shares some obsessive-compulsive features. Patients have the
A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The newer antifungal agents itraconazole, terbinafine and fluconazole have become available to treat onychomycosis over the last 10 years. During this time period these agents have superseded griseofulvin as the agent of choice for onychomycosis. Unlike griseofulvin, the new agents have a broad
Evaluation of ketoconazole.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The pharmacology, microbiology, pharmacokinetics, clinical use, adverse effects, dosage and administration, and drug interactions of ketoconazole are reviewed. Ketoconazole, a new orally active antifungal agent, is an imidazole derivative structurally related to miconazole and clotrimazole. It
Aromatherapy and Essential Oils: A Map of the Evidence
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND
Oral 8-methoxypsoralen is the drug of choice in photochemotherapy of several dermatoses, e.g., vitiligo and psoriasis. The aim of this trial is to produce a new preparation of the drug, which is able to overcome the difficulties met with the oral use of the older preparations.
METHODS
A
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
